Johnson_Shanda_**-Jan-****’ Page * of *
Shanda Johnson
Sr. CRA
ICON Clinical Research
Wylie, TX, USA
Education
Collin College
Associate of Science Degree
Major: Respiratory Therapy
American Intercontinental University
Bachelor of Science
Major: Healthcare Administration
University of Texas at Arlington
Master of Science
Major: Healthcare Administration
Summary
Over 20 years of experience working in clinical research with over 5 years of experience as CRA
Clinical Research Therapeutic Areas include:
Indication Phase I, II, III, or IV Highest Role Within Indication
Cardiology II, III Sr. CRA
Dermatology III CRA II
Neurology II, III, IV SR. CRA, Manager
Endocrinology II, III CRA I
Genetics II, III CRA I
Infectious Disease II, III CRA II
Respiratory II, III CRA II
Head and Neck Oncology II, III Manager
Melanoma II, III Manager
Sarcoma II, III Manager
Neuro Oncology I, II, III, IV Sr. CRA, Manager
Professional Licenses/Affiliations/Memberships:
Johnson_Shanda_17-Jan-2023 Page 2 of 5
American Heart Association BLS Instructor
Society of Clinical Research Associates
National Board of Respiratory Therapy
Licensed Registered Respiratory Therapist
Experience in Electronic Data Capture trials:
RAVE, CSIV, InVicro, Quentry, InForm, REDCap, Citrix, Medidata, IMPACT, BioClinical
Languages (fluency, verbal and written): English Johnson_Shanda_17-Jan-2023 Page 3 of 5
Professional Experience
ICON Clinical Research
Sr. CRA
January 2023
Job Description
Study Assignments
Role(s): Sr. CRA Period(s):
Jan 2023- Current
Identify, select, initiate, and close-out appropriate investigational sites for clinical studies. Monitor those sites in order to ensure that studies are carried out according to the study protocol, ICON SOPs/WPs,
applicable regulations and the principles of ICH-GCP. Depending upon experience, become involved when
required in other areas of study management and staff training and contribute to the review of ICON systems and procedures as appropriate. Provide a benchmark of
monitoring competence to inexperienced / less
experienced colleagues.
Role(s):
Sr. CRA
Period(s):
Jan 2023 – Current
Project Description
1. Unblinded Sr. CRA (Jan 2023 – July 2023)
Protocol 80202135SJS2001:A Randomized,
Placebo-Controlled, Double-Blind, Multicenter
Study to assess the efficacy of Nipocalimab in
Subjects with Primary Sjogren's Syndrome (pSjS).
2. Blinded Sr. CRA (Jan 2023 – present)
Protocol MOM-M281-006: Efficacy and Safety of
M281 in Adults with Warm Autoimmune Hemolytic
Anemia: A Multicenter, Randomized, Double-blind,
Placebo-controlled Study with a Long-term Open-
label Extension
3. Blinded Sr. CRA (Jan 2023 – present)
Protocol VAC52416BAC3001: Efficacy and Safety
of M281 in Adults with Warm Autoimmune
Hemolytic Anemia: A Multicenter, Randomized,
Double blind, Placebo controlled Study with a
Long-term Open-label Extension Randomized,
Double-Blind, Placebo-controlled, Multicenter Ph 3 Study to Assess the Efficacy, Safety And
Immunogenicity of Vaccination With ExPEC9V in
the Prevention of Invasive Extraintestinal
Pathogenic E-coli in Adults over 60 with a History of UTI
Johnson_Shanda_17-Jan-2023 Page 4 of 5
Plus Therapeutics
Contract Consultant
Jan 2022 to Dec 2022
Identify, select, initiate, and close-out appropriate investigational sites for clinical studies. Monitor those sites in order to ensure that studies are carried out according to the study protocol, applicable regulations and the principles of ICH-GCP, and encourage patient recruitment suggesting strategies as appropriate per study sponsor. Assist with all protocol submissions at a sponsor level, create source documents, point of contact with study vendors, ensure all site study team members had proper access to all required study systems, assist with budget creation and negotiations between the sponsor and sites, created newsletters/training slides/training documents, and facilitated presentations.
UT Southwestern Medical Center of Dallas
Clinical Research Manager
Apr 2019 to Oct 2021
Review proposed trials and present to the entire study team, review and negotiate budgets, oversees preparation of all IRB documents, ensure all CITI and regulatory trainings are up to date with the entire study team, ensure FDA compliance and all other regulatory entities, oversee all ongoing research projects by the team and monitor profitability, direct oversight of the projects finances and invoices for payment, ensure training of the study staff, oversee marketing strategies, maintain collaborative relationship with the study team and basic science facilities, and oversee the immediate study team members.
United BioSource Corporation
Sr. CRA
May 2017 to May 2019
Identify, select, initiate and close-out appropriate investigational sites for clinical studies. Monitor those sites in order to ensure that studies are carried out according to the study protocol and in accordance with UBC SOPs, applicable regulations and the principles of ICH-GCP, and encourage patient recruitment suggesting strategies as appropriate per study sponsor, Provide a benchmark of monitoring competence to inexperienced / less experienced colleagues.
Quintiles IMS
Sr. CRA
November 2015 to May 2017
Identify, select, initiate, and close-out appropriate investigational sites for clinical studies. Monitor those sites in order to ensure that studies are carried out according to the study protocol, Quintiles SOPs/WPs, applicable regulations and the principles of ICH-GCP. Depending upon experience, become involved when required in other areas of study management and staff training and contribute to the review of Quintiles systems and procedures as appropriate, and encourage patient recruitment suggesting strategies as appropriate per study sponsor,
Childrens Medical Center of
Dallas
Clinical Research Coordinator
October 2005 to November 2015
Facilitate in research protocol evaluation and implementation, evaluate study coverage analysis and study feasibility, execute study start-up and close-out procedures, patient recruitment and study Johnson_Shanda_17-Jan-2023 Page 5 of 5
follow-up, study record maintenance including patient binders and regulatory binders, IRB regulatory study submission, working relationship with sponsors acting as a liaison with the PI’s, precepting new Study Coordinators, and assist with Research Workshops and Conferences
Publications:
N/A